Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial. This is ...
Integrative clinical, genomic, and transcriptomic characterization of circulating KIM-1 in metastatic RCC. Second-line outcomes in metastatic renal cell carcinoma: The role of International Metastatic ...
Children with higher birth weight and body mass index, as well as taller height, are at a greater risk of developing renal cell carcinoma later in life, according to new study findings. Birth weight, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback